A temporary elevation of serum alkaline phosphatase has been described
in young children who have no evidence of liver or bone disease. This
phenomenon has been termed benign hyperphosphatasemia of infancy. Its
occurrence is described in three children undergoing chemotherapy for
acute lymphoblastic leukemia and lymphoma. All three children were in
remission and in the consolidation or maintenance phase of their ther
apy when the hyperphosphatasemia occurred, All children were also rece
iving methotrexate (IM and TV), oral 6-mercaptopurine, and oral sulfam
ethoxazole/trimethoprim. Although these agents are associated with hep
atotoxicity other liver transaminases (ALT, AST) remained at normal co
ncentrations, and there was an elevation only in the bone isoenzyme of
alkaline phosphatase, thus making hepatic toxicity an unlikely etiolo
gy for the hyperphosphatasemia. No alteration in chemotherapy was nece
ssary for resolution of the elevated alkaline phosphatase in these chi
ldren.